Fortress Biotech, Inc. (FBIO) IPO - S-1 Filing, Stock & Insider Activity
Fortress Biotech, Inc. IPO - Status & S-1 Filing
- Ticker: FBIO
- Status: Registered - S-1 filed with the SEC
- S-1 filed: 2025-12-16
- Exchange: NASDAQ
- Expected price range: not yet disclosed (set in a later S-1/A or pricing amendment)
- Shares offered: 600,000
- SEC CIK: 0001429260 · View the S-1 on SEC EDGAR →
Track every registration update on the InsiderAlpha IPO tracker.
Last SEC filing
Fortress Biotech, Inc. (FBIO) has filed 1 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-25. 2 Form 8-K material event filings were reported by FBIO in the last 90 days. InsiderAlpha tracks every FBIO SEC filing - Form 4, Form 144, and 8-K - in real time, including Rule 10b5-1 plan detection.
About Fortress Biotech, Inc. (FBIO)
Fortress Biotech, Inc. trades under the ticker FBIO. InsiderAlpha tracks 7 primary SEC Form 4 filings from 3 reporting insiders for FBIO since 2024, sourced directly from SEC EDGAR.
| Sector | Health Care insider trading |
|---|---|
| SIC classification | Pharmaceutical Preparations (SIC 2834) |
| SEC CIK | 0001429260 |
90-Day SEC Filing Activity
| Form 4 filings (90d) | 1 |
|---|---|
| Form 8-K filings (90d) | 2 |
| Latest Form 4 filing | 2026-06-25 |
Recent FBIO Insider Transactions (Form 4)
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| David Jin | Chief Financial Officer | A - Grant or award | 400.0K | $0.00 | - | SEC | |
| David Jin | Chief Financial Officer | A - Grant or award | 3.0K | $2.18 | $6K | SEC | |
| Lindsay A. Md Rosenwald | PRESIDENT, CEO & CHAIRMAN | A - Grant or award | 475.4K | $0.00 | - | SEC | |
| Michael S. Weiss | Executive Vice Chairman | A - Grant or award | 475.4K | $0.00 | - | SEC | |
| David Jin | Chief Financial Officer | A - Grant or award | 2.7K | $1.31 | $4K | SEC | |
| David Jin | Chief Financial Officer | A - Grant or award | 1.00M | $0.00 | - | SEC | |
| David Jin | Chief Financial Officer | A - Grant or award | 2.6K | $1.23 | $3K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Fortress Biotech, Inc. (FBIO). Updated in real time as new filings are submitted to the SEC.
Most-Active FBIO Insiders - Last 90 Days
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| David Jin | 1 | - |
Recent FBIO Form 8-K Material Events
- - Item 5.07 [SEC]
- - Item 2.02, 9.01 [SEC]
- - Item 2.02, 9.01 · Earnings · neutral [SEC]
Fortress Biotech issued a press release on March 31, 2026 announcing financial results for the year ended December 31, 2025, along with a corporate update. The filing provides standard annual financial results without explicit beat/miss or guidance language. - - Item 8.01, 9.01 · Acquisition · positive [SEC]
Fortress Biotech's majority-owned subsidiary Cyprium Therapeutics completed the sale of its Rare Pediatric Disease Priority Review Voucher (PRV) for $205 million in gross proceeds. Fortress expects to receive at least $100 million from Cyprium through pro rata dividends and inter - - Item 1.01, 2.03, 8.01, 9.01 · Acquisition · positive [SEC]
Fortress Biotech's subsidiary Cyprium Therapeutics entered into a definitive agreement to sell a Rare Pediatric Disease Priority Review Voucher (PRV) for $205 million in cash. The PRV was originally issued following FDA approval of ZYCUBO® for Menkes disease. The transaction is s
Recent Insider Filings
- - David Jin (Chief Financial Officer)
- - David Jin (Chief Financial Officer)
- - Lindsay A. Md Rosenwald (PRESIDENT, CEO & CHAIRMAN)
- - Michael S. Weiss (Executive Vice Chairman)
- - David Jin (Chief Financial Officer)
Form 4 Transaction Code Reference
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in FBIO insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
FBIO Insider Trading - FAQ
- What is the latest insider trade for FBIO?
- Fortress Biotech, Inc. (FBIO) had 1 insider filings in the last 90 days, with the most recent on 2026-06-25. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
- How many insiders are buying FBIO stock?
- 0 insider purchases of FBIO were filed in the last 90 days.
- How many insiders are selling FBIO stock?
- 0 insider sales of FBIO were filed in the last 90 days.
- Where can I see FBIO SEC filings (Form 4, 10-K, 10-Q, 8-K)?
- This page tracks FBIO Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care Companies with Insider Activity
Other companies in the InsiderAlpha index with a significant SEC Form 4 insider-trading footprint:
- $GNPX Genprex, Inc.
- $GOVX GeoVax Labs, Inc.
- $GRI GRI Bio, Inc.
- $GRML Greenland Mines Ltd
- $GTBP GT Biopharma, Inc.
- $HYEX HEALTHY EXTRACTS INC.
- $ICU SeaStar Medical Holding Corp
- $IMA ImageneBio, Inc.
- $IVF INVO Fertility, Inc.
- $JAGX Jaguar Health, Inc.
Related Companies - Recent Insider Activity
- UNITED THERAPEUTICS Corp (UTHR)
- Liquidia Corp (LQDA)
- BeOne Medicines Ltd. (ONC)
- PERRIGO Co plc (PRGO)
- Processa Pharmaceuticals, Inc. (PCSA)
- Nuvalent, Inc. (NUVL)
- CYTOKINETICS INC (CYTK)
- Elanco Animal Health Inc (ELAN)
- Avalo Therapeutics, Inc. (AVTX)
- NATURES SUNSHINE PRODUCTS INC (NATR)
Learn More
- What is SEC Form 4?
- How to read insider buying signals
- Rule 10b5-1 trading plans explained
- The cluster buying signal
Open the live FBIO dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.